OUR SERVICES
Eight precision tests. One trusted partner.
PRECISION TESTING
From embryo genetics to the microbiome, immunity, stimulation response, and metabolic predisposition.
01 / EMBRYO GENETIC TESTING
01
PGT-A / ANEUPLOIDY
Using a Next Generation Sequencing platform to assess embryo biopsies for chromosomal abnormalities — providing the precision needed to identify which embryos have the best chance of leading to a healthy pregnancy.
02
PGT-M / MONOGENIC
Assesses embryo biopsies for hereditary variants from parental origin. Custom probes are developed in collaboration with patients to achieve optimal accuracy — and may reduce the need for additional family member testing.
03
PGT-SR / STRUCTURAL
Assesses embryo biopsies for inherited abnormal karyotypes. Work directly with Conceivium to evaluate your specific case and develop a tailored testing strategy.
02 / REPRODUCTIVE ENVIRONMENT
04
REPROMAP / MICROBIOME
ReproMAP uses Next Generation Sequencing for metagenomic analysis of vaginal swabs, menstrual blood, and semen. Species-level identification ensures we accurately characterize microbes — going beyond what genus-level testing can detect.
FemaleMAP assesses vaginal swab and menstrual blood samples. PartnerMAP adds semen analysis for a fuller picture of the fertility couple.
05
REPROMMUNITY / IMMUNE
Reprommunity uses qPCR, flow cytometry, and ELISA techniques to evaluate the immunogenetics and immune cell profiles of both partners — determining the optimal conditions for conception.
Detects immune cell ratios, cytokine ratios, T cell response, immune compatibility, parental immune genotypes, and parental immunogenetic overlaps.
06
REPRODUO / BUNDLED PACKAGE
Combines our ReproMAP (FemaleMAP) test with Reprommunity to provide a complete snapshot of the couple’s microbiome and immune systems — in one comprehensive bundle.
The most efficient way to understand both biological systems that influence fertility outcomes.
03 / PERSONALIZED RESPONSE
07
FSH RECEPTOR / STIMULATION
Uses qPCR technology to determine a patient’s optimal response to FSH medications — helping to optimize response during medical stimulation and reduce the risk of low-response cycles.
08
GMP / METABOLIC
FTO and MC4R Test. Uses qPCR technology to determine a patient’s specific genotype and assess their genetic predisposition to metabolic challenges — evaluating how the body responds to and produces hunger hormones.
F.A.Q.
Clear explanations of our microbiome and immune testing.
TEST EXPLANATIONS
Our endometrial microbiome test uses a non-invasive at-home collection method to determine what microbes are present in your uterus. Through the menstrual blood sample you send us, we use our advanced genetic technologies to take the microbes from your sample and let us know exactly which microbes might be populating your uterus. We are looking for a specific group of bacteria called “Lactobacillus” which is a classification of bacteria that has been shown to grow a favourable environment in your uterus. Our test even lets us tell you what kind of “Lactobacillus” and other microbes are present down to the species level (think Rottweiler vs large dog), which lets this test help guide your treatment and fertility journey more specifically than other available test.
In women with recurrent implantation failure or recurrent pregnancy loss they underwent microbial sequencing like our test here. They separated the groups into “dysbiosis” (bad microbes present) and “normal Biosis” (good microbes present). The dysbiosis group underwent antibiotics, probiotics or no treatment. The group receiving antibiotics and probiotics had significantly higher ongoing pregnant rates compared the non-treatment group (Iwami 2022;2025). In another repeated implantation failure study, 88.9% of women with uterine dysbiosis achieved clinical pregnancy after antibiotics and probiotics (Hiratsuka 2025).
Patients experiencing recurrent implantation failure and/or recurrent pregnancy loss.
TEST EXPLANATIONS
Our immune testing panel combines cellular tests with genetic tests to look at your overall immune system and your compatibility with your partner. This test determines the “goldilocks zone” required for embryo implantation. We do not want your immune system over or under reactive when your embryo is implanting. This test can determine factors of your immune system that can contribute to hyperactivity or under activity in your critical immune cells.
Women with repeated implantation failure and recurrent loss had higher levels of NK cells compared to patients with typical pregnancies (Woon 2022).
Blood samples are taken from both partners and are sent to our lab for cellular and genetic investigations.
Patients experiencing recurrent implantation failure and/or recurrent pregnancy loss.
